Clover Health Investments (CLOV) Cash & Current Investments (2019 - 2026)

Clover Health Investments has reported Cash & Current Investments for 8 years, with the latest figure at $197.5 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Current Investments rose 23.34% year-over-year to $197.5 million; the trailing twelve-month figure through Mar 2026 stood at $197.5 million (up 23.34% YoY), and the FY2025 full-year result was $80.1 million, down 58.84% from the prior year.
• Cash & Current Investments for Q1 2026 stood at $197.5 million, up from $80.1 million in the prior quarter.
• The five-year high for Cash & Current Investments was $536.7 million in Q3 2022, with the low at $80.1 million in Q4 2025.
• Historically, Cash & Current Investments has averaged $271.6 million across 5 years, with a median of $264.4 million in 2024.
• Annual changes were most pronounced in 2022 — Cash & Current Investments surged 149.12% — and 2025, when it tumbled 58.84%.
• Clover Health Investments' Cash & Current Investments stood at $293.3 million in 2022, then plunged by 53.94% to $135.1 million in 2023, then jumped by 44.03% to $194.6 million in 2024, then plunged by 58.84% to $80.1 million in 2025, then jumped by 146.58% to $197.5 million in 2026.
• The last three Cash & Current Investments figures came in at $197.5 million (Q1 2026), $80.1 million (Q4 2025), and $201.0 million (Q3 2025), per Business Quant data.